Cargando…

Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status

SIMPLE SUMMARY: Long-term survival in patients with oropharyngeal cancer is sparsely studied, but atypical recurrences in human papillomavirus-positive (HPV+) oropharyngeal cancer have been indicated. Furthermore, while the role of HPV is well established in tonsillar and base of tongue cancer, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wendt, Malin, Hammarstedt-Nordenvall, Lalle, Zupancic, Mark, Friesland, Signe, Landin, David, Munck-Wikland, Eva, Dalianis, Tina, Näsman, Anders, Marklund, Linda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196945/ https://www.ncbi.nlm.nih.gov/pubmed/34070952 http://dx.doi.org/10.3390/cancers13112553

Ejemplares similares

Post-Treatment Neck Dissection of Tonsillar and Base of Tongue Squamous Cell Carcinoma in the Era of PET-CT, HPV, and p16
por: Landin, David, et al.
Publicado: (2022)

Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer
por: Marklund, Linda, et al.
Publicado: (2012)

HLA Class I and II Expression in Oropharyngeal Squamous Cell Carcinoma in Relation to Tumor HPV Status and Clinical Outcome
por: Näsman, Anders, et al.
Publicado: (2013)

Human papillomavirus and survival of patients per histological subsite of tonsillar squamous cell carcinoma
por: Haeggblom, Linnea, et al.
Publicado: (2018)

High Levels of FGF11 Correlate with Poor Survival in Patients with Human Papillomavirus (HPV)-Positive Oropharyngeal Squamous Cell Carcinoma
por: de Flon, Caroline Haglund, et al.
Publicado: (2023)

Tumor Infiltrating CD8(+) and Foxp3(+) Lymphocytes Correlate to Clinical Outcome and Human Papillomavirus (HPV) Status in Tonsillar Cancer
por: Näsman, Anders, et al.
Publicado: (2012)

Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival
por: Näsman, Anders, et al.
Publicado: (2013)

Tumour inflammation signature and expression of S100A12 and HLA class I improve survival in HPV-negative hypopharyngeal cancer
por: Mints, Michael, et al.
Publicado: (2021)

Impact of HPV in Oropharyngeal Cancer
por: Marklund, Linda, et al.
Publicado: (2011)

Adenoid Cystic Carcinoma (AdCC): A Clinical Survey of a Large Patient Cohort
por: Zupancic, Mark, et al.
Publicado: (2023)

Analysis of Human Papillomavirus (HPV) and Polyomaviruses (HPyVs) in Adenoid Cystic Carcinoma (AdCC) of the Head and Neck Region Reveals Three HPV-Positive Cases with Adenoid Cystic-like Features
por: Zupancic, Mark, et al.
Publicado: (2022)

Psoriasin expression is associated with survival in patients with human papillomavirus-positive base of tongue squamous cell carcinoma
por: Zupancic, Mark, et al.
Publicado: (2021)

Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years
por: Haeggblom, Linnea, et al.
Publicado: (2017)

Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome
por: Ramqvist, Torbjörn, et al.
Publicado: (2018)

Special Issue “HPV in the Head and Neck Region”
por: Dalianis, Tina, et al.
Publicado: (2021)

Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams)
por: Grønhøj, Christian, et al.
Publicado: (2018)

Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome
por: Sivars, Lars, et al.
Publicado: (2014)

Radiotherapy—Dose Escalated for Large Volume Primary Tumors—And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck—A Randomized Phase II Trial
por: Mercke, Claes, et al.
Publicado: (2023)

No evidence for human papillomavirus having a causal role in salivary gland tumors
por: Haeggblom, Linnea, et al.
Publicado: (2018)

Treatment and outcome among patients with laryngeal squamous cell carcinoma in Stockholm—A population‐based study
por: Blomkvist, Rasmus, et al.
Publicado: (2023)

Special Issue “HPV in the Head and Neck Region 2.0”
por: Dalianis, Tina, et al.
Publicado: (2023)

Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008–2018, and perspectives on cancer prevention
por: Du, Juan, et al.
Publicado: (2020)

Human Papillomavirus (HPV) 16 E6 Variants in Tonsillar Cancer in Comparison to Those in Cervical Cancer in Stockholm, Sweden
por: Du, Juan, et al.
Publicado: (2012)

The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil
por: Menezes, Fabrício dos Santos, et al.
Publicado: (2020)

Incidence of IP and risk of malignant transformation in the Swedish population 1960–2010
por: Elliot, Alexandra, et al.
Publicado: (2016)

Whole-Exome Sequencing of HPV Positive Tonsillar and Base of Tongue Squamous Cell Carcinomas Reveals a Global Mutational Pattern along with Relapse-Specific Somatic Variants
por: Ährlund-Richter, Andreas, et al.
Publicado: (2021)

Correlation of LMP10 Expression and Clinical Outcome in Human Papillomavirus (HPV) Positive and HPV-Negative Tonsillar and Base of Tongue Cancer
por: Tertipis, Nikolaos, et al.
Publicado: (2014)

Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3
por: Bersani, Cinzia, et al.
Publicado: (2017)

Prognostic Markers and Driver Genes and Options for Targeted Therapy in Human-Papillomavirus-Positive Tonsillar and Base-of-Tongue Squamous Cell Carcinoma
por: Näsman, Anders, et al.
Publicado: (2021)

ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer
por: Gebre-Medhin, Maria, et al.
Publicado: (2021)

Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects
por: Embring, Anna, et al.
Publicado: (2023)

Societal cost of oropharyngeal cancer by human papillomavirus status, cancer stage, and subsite
por: Silfverschiöld, Maria, et al.
Publicado: (2019)

Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost
por: Embring, Anna, et al.
Publicado: (2023)

Oropharyngeal Cancer Epidemic and Human Papillomavirus
por: Ramqvist, Torbjörn, et al.
Publicado: (2010)

Prevalence of Human Papillomavirus (HPV) in Oesophageal Squamous Cell Carcinoma in Relation to Anatomical Site of the Tumour
por: Löfdahl, Hedvig E., et al.
Publicado: (2012)

Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors
por: Stern, Peter L., et al.
Publicado: (2021)

Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer
por: Lindquist, D, et al.
Publicado: (2014)

Distribution of sentinel nodes from parotid tumors–A feasibility study
por: Hammarstedt‐Nordenvall, Lalle, et al.
Publicado: (2023)

Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations
por: Holzhauser, Stefan, et al.
Publicado: (2021)

Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy
por: DALIANIS, TINA
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3f5eevjcm8sds3vg5sm6f0us35